Robuta

https://fibrofoundation.org/fcf-grants/development-and-implementation-of-3d-in-vitro-fibrolamellar-carcinoma-tumor-models/?mo=3&yr=2026 Development and implementation of 3D in vitro fibrolamellar carcinoma tumor models - Fibrolamellar... SUmmary of 2024 grant to Ohio State University to use a hydrogel system to create FLC tumor models from preserved patient samples in vitrofibrolamellar carcinomadevelopmentimplementation https://pangeabiomed.com/?publications=fibrolamellar-carcinoma-transcriptomic-based-treatment-prediction-complete-response-after-nivolumab-and-ipilimumab Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after... Raanan Berger, Gal Dinstag, Omer Tirosh, Eyal Schiff, David Kleiner, Kenneth D Aldape, Eytan Ruppin, Tuvik Beker and Razelle Kurzrock fibrolamellar carcinomabasedtreatmentpredictioncomplete https://fibrofoundation.org/flc-research/predictors-of-outcome-in-patients-with-fibrolamellar-carcinoma-analysis-of-the-national-cancer-database/?id=378747056&ajaxCalendar=1&mo=6&yr=2024 Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer... Publication retrospectively analyzing the clinicopathological factors and treatments affecting overall survival in FLC using the National Cancer Database in patients https://www.themednet.org/how-do-you-choose-first-or-second-line-systemic-therapy-for-fibrolamellar-hepatocellular-carcinoma?from=pediatric-hem-onc How do you choose first or second-line systemic therapy for fibrolamellar hepatocellular carcinoma?... Physician discussion: How do you choose first or second-line systemic therapy for fibrolamellar hepatocellular carcinoma?. See expert answers and community... how do you https://fibrofoundation.org/fcf-grants/development-and-characterization-of-patient-derived-models-of-fibrolamellar-carcinoma/ Development and Characterization of Patient-derived Models of Fibrolamellar Carcinoma -... Summary of 2023 grant to Fred Hutchinson Cancer Center to evaluate selective inhibitors of PLK1 that are currently in clinical development in human models of... developmentcharacterizationpatientderivedmodels